To include your compound in the COVID-19 Resource Center, submit it here.

ATX-MS-1467: Completed Phase I enrollment

Apitope completed enrollment of an open-label, international Phase I trial evaluating 5 dose

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE